Literature DB >> 7504658

Biochemical and immunological characterization of the human carcinoma-associated antigen MH 99/KS 1/4.

M P Schön1, M Schön, M J Mattes, R Stein, L Weber, S Alberti, C E Klein.   

Abstract

We have characterized the 38-kDa transformation-associated membrane glycoprotein MH 99, whose expression is highly elevated in many epithelial malignancies. A spontaneous cleavage of MH 99 into a 32- and a 6-kDa chain in some carcinoma cell lines was recently shown. Sequence homologies to nidogen, a matrix-adhesion molecule, support the suggestion of a receptor-like function. In this study, we characterized biochemical and immunogenic aspects of MH 99. Transformed epithelial cell lines which do not spontaneously cleave MH 99 were exposed to 8 proteases with distinct specificities. Each of the enzymes produced similar specific fragmentation into chains of about 30 to 32 and 6 kDa, indicating a characteristic cleavage site of MH 99. The fragments were not distinguishable from those in carcinoma cells showing spontaneous cleavage of MH 99. The specific fragmentation depends on the localization in intact membranes and is not shared by other membrane proteins. N-glycosylation of MH 99 of about 4 kDa was exclusively found on the 32-kDa fragment. Characterization of antigenic epitopes was performed using 16 different monoclonal antibodies (MAbs). Only 2 independent determinants were found. One is located on the 32-kDa chain and is recognized only by the MM 104 MAb. The other 15 antibodies bind to a dominant epitope on the 6-kDa fragment which can be divided into 3 overlapping sub-epitopes. The unique features of MH 99 indicate that its immunogenic epitopes are mainly located at its 6-kDa chain, and support the suggestion of a transformation-associated cell-surface receptor which might be proteolytically regulated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504658     DOI: 10.1002/ijc.2910550619

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions.

Authors:  M Balzar; I H Briaire-de Bruijn; H A Rees-Bakker; F A Prins; W Helfrich; L de Leij; G Riethmüller; S Alberti; S O Warnaar; G J Fleuren; S V Litvinov
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  The human hair follicle: glycoprotein-related antigenic profile of distinct keratinocyte populations in vivo and their alterations in vitro.

Authors:  M P Schön; U Blume-Peytavi; M Schön; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

3.  MMTV/LTR Promoter-Driven Transgenic Expression of EpCAM Leads to the Development of Large Pancreatic Islets.

Authors:  Jeffrey R Vercollone; Maarten Balzar; Sergey V Litvinov; Wendy Yang; Vincenzo Cirulli
Journal:  J Histochem Cytochem       Date:  2015-08       Impact factor: 2.479

Review 4.  The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.

Authors:  Manon J Winter; Iris D Nagtegaal; J Han J M van Krieken; Sergey V Litvinov
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE.

Authors:  Tomaž Žagar; Miha Pavšič; Aljaž Gaber
Journal:  PeerJ       Date:  2021-05-21       Impact factor: 2.984

6.  Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1.

Authors:  Y Tomita; F Arakawa; T Yamamoto; M Kuwahara; R Watanabe; H Iwasaki; M Kikuchi; M Kuroki
Journal:  Jpn J Cancer Res       Date:  2000-02

7.  EpCAM proteolysis: new fragments with distinct functions?

Authors:  Ulrike Schnell; Jeroen Kuipers; Ben N G Giepmans
Journal:  Biosci Rep       Date:  2013-03-19       Impact factor: 3.840

8.  High expression of TROP2 correlates with poor prognosis in pancreatic cancer.

Authors:  D Fong; P Moser; C Krammel; J M Gostner; R Margreiter; M Mitterer; G Gastl; G Spizzo
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

9.  Trop-2 is a determinant of breast cancer survival.

Authors:  Federico Ambrogi; Marco Fornili; Patrizia Boracchi; Marco Trerotola; Valeria Relli; Pasquale Simeone; Rossana La Sorda; Rossano Lattanzio; Patrizia Querzoli; Massimo Pedriali; Mauro Piantelli; Elia Biganzoli; Saverio Alberti
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

Review 10.  Current View on EpCAM Structural Biology.

Authors:  Aljaž Gaber; Brigita Lenarčič; Miha Pavšič
Journal:  Cells       Date:  2020-05-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.